AViTA Corporation (TPEX:4735)
Taiwan · Delayed Price · Currency is TWD 32.70
-0.45 (-1.36%)
Jan 22, 2026, 1:30 PM CST
AViTA Revenue
AViTA had revenue of 236.28M TWD in the quarter ending September 30, 2025, a decrease of -12.24%. This brings the company's revenue in the last twelve months to 896.85M, up 2.67% year-over-year. In the year 2024, AViTA had annual revenue of 927.30M with 5.48% growth.
Revenue (ttm)
896.85M
Revenue Growth
+2.67%
P/S Ratio
1.42
Revenue / Employee
10.68M
Employees
84
Market Cap
1.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 927.30M | 48.22M | 5.48% |
| Dec 31, 2023 | 879.08M | -321.84M | -26.80% |
| Dec 31, 2022 | 1.20B | -1.12B | -48.35% |
| Dec 31, 2021 | 2.33B | -274.96M | -10.57% |
| Dec 31, 2020 | 2.60B | 1.35B | 108.41% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Center Laboratories | 1.57B |
| Oneness Biotech | 117.33M |
| Polaris Group | 70.83M |
| Lumosa Therapeutics | 42.59M |
| Caliway Biopharmaceuticals | 34.99M |